Key Metrics
4.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.81
5-Year SI
5-year SI
- N/A 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
0.79
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Leukemia and Lymphoma ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy
- 15 Apr 24
- Leukemia & Lymphoma
-
Full paper
The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA)
- 15 Apr 24
- Leukemia & Lymphoma
-
Full paper
Two recurrent types of IGH::5′ BCL2 breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the VDJ and class switch recombination processes, respectively
- 12 Apr 24
- Leukemia & Lymphoma
-
Full paper
Successful treatment with cladribine in a patient with Rosai–Dorfman disease complicated by severe, prolonged marrow aplasia
- 12 Apr 24
- Leukemia & Lymphoma
-
Full paper
The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis
- 10 Apr 24
- Leukemia & Lymphoma
-
Full paper
Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances
- 9 Apr 24
- Leukemia & Lymphoma
Scite analysis
Powered by scite_
13.4k articles received 144.5k citations see all
- 6,638 Supporting
- 133,045 Mentioning
- 1,264 Contrasting
Editorial notices
- 13 Retractions
- 0 Withdrawals
- 25 Corrections
- 27 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
27%
4 to 6 months
52%
7 to 9 months
17%
Above 9 months
4%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Leukemia and Lymphoma been actively publishing?
Leukemia and Lymphoma has been in operation since 1989 till date.
What is the publishing frequency of Leukemia and Lymphoma ?
Leukemia and Lymphoma published with a Monthly frequency.
How many articles did Leukemia and Lymphoma publish last years ?
In 2023, Leukemia and Lymphoma published 285 articles.
What is the eISSN & pISSN for Leukemia and Lymphoma ?
For Leukemia and Lymphoma,eISSN is 1029-2403 and pISSN is1042-8194.
What is Citescore for Leukemia and Lymphoma ?
Citescore for Leukemia and Lymphoma is 4.2.
What is SNIP score for Leukemia and Lymphoma ?
SNIP score for Leukemia and Lymphoma is 0.79.
Who is the publisher of Leukemia and Lymphoma ?
TAYLOR & FRANCIS LTD is the publisher of Leukemia and Lymphoma.